The lawsuits, which Novo said it filed against five companies in US federal courts in those states on Tuesday, say that these companies shouldn’t be promoting the compounded drugs as Wegovy. The suits say that kind of marketing is trademark infringement, false advertising and unfair competition, and ask the courts to get the companies to stop using the Wegovy name.
The lawsuits were filed against Pro Health Investments, Champion Health & Wellness Clinics, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.